CLIP
DGX icon

Colter Lewis Investment Partners’s Quest Diagnostics DGX Stock Holding History

Colter Lewis Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Hold
1,751
– – 0.17% 84
2026
Q1 		$343K Hold
1,751
– – 0.32% 83
2025
Q4 		$304K Buy
+1,751
New +$319K 0.35% 62

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Colter Lewis Investment Partners's DGX Position: Q2 2026 in Review

Colter Lewis Investment Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,751 shares worth $371K. The position accounts for 0.17% of the portfolio, ranked #84.

Colter Lewis Investment Partners first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Colter Lewis Investment Partners held 1,751 shares of Quest Diagnostics worth $371K as of Q2 2026.
  • Colter Lewis Investment Partners left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.17% of Colter Lewis Investment Partners's portfolio in Q2 2026, its #84 holding.
  • Colter Lewis Investment Partners first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Colter Lewis Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.